The trajectory of companies tied to flagship drugs like Viagra presents a nuanced investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the loss of exclusivity in key territories has introduced considerable risk . Investors are now assessing the consequences of generic c